The vascular dementia treatment market comprises neuroprotective drugs, cell therapy, gene therapy and others. Vascular dementia occurs due to conditions that block or reduce blood flow to the brain, depriving brain cells of vital oxygen and nutrients. This leads to gradual deterioration of cognitive functions such as thinking, remembering, reasoning, and planning. Neuroprotective drugs attempt to slow down or halt the damage caused to neurons as a result of ischemia or reduced blood flow. Cell therapy involves transplantation of stem cells in the brain for regeneration of damaged brain tissues. Gene therapy aims to deliver genes into cells to compensate for abnormal genes that are causing or linked to disease.
The Global vascular dementia treatment market is estimated to be valued at US$ 3.10 Billion in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the vascular dementia treatment market are CSPC Ouyi Pharmaceutical, Aptinyx, Oryzon Genomics, Lundbeck, Novartis. Key players CSPC Ouyi Pharmaceutical and Lundbeck currently dominate the market with their neuroprotective drugs for vascular dementia.
There is a growing demand for effective treatment of vascular dementia worldwide as it is one of the leading causes of dementia after Alzheimer's disease. The rising geriatric population and increasing incidence of cerebrovascular diseases are major drivers for the growth of this market.
Many companies are investintg in R&D of cell and gene therapies to cure vascular dementia. Regionally, North America dominates the global vascular dementia treatment market due to high healthcare spending and presence of major market players. However, Asia Pacific market is expected to grow at a high CAGR due to rising economies, growing geriatric population and increased investment in healthcare sector.
Market Key Trends
One of the key trends in the vascular dementia treatment market is the increasing focus on development of neurotherapeutics through stem cell-based therapies and regenerative medicine. Preclinical research is being conducted to evaluate the potential of stem cell therapies such as neural stem cell transplantation in repairing damaged neural circuits and restoring cognitive functions in vascular dementia. Companies are also exploring gene therapy as a potential cure by delivering neurotrophic factors or modifying genes linked to cerebral ischemia. This shift from symptomatic drugs to disease-modifying therapies presents significant opportunities for growth in the long run.
Porter's Analysis
Threat of new entrants: Low barriers to entry due to limited production capacities required, though R&D costs acts as deterrent.
Bargaining power of buyers: Buyers have moderate bargaining due to availability of substitute products and price sensitivity for pharmaceutical products.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to differentiated proprietary products and technologies required.
Threat of new substitutes: Threat of new substitutes is moderate as alternative treatment options are available with limited efficacy.
Competitive rivalry: High due to increasing generic competition and intensive efforts on new product development.
Geographical Regions
North America holds the largest share of the vascular dementia market currently due to rising geriatric population, higher healthcare spending and presence of major players in the region.
Asia Pacific is poised to register the fastest growth over the forecast period due to increasing healthcare expenditure, prevalence of lifestyle diseases and rising patient awareness about treatment options in the region.
What Are The Key Data Covered In This Vascular Dementia Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Vascular Dementia 's growth between 2024 and 2031.
:- Accurate calculation of the size of the Vascular Dementia and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Vascular Dementia Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Vascular Dementia vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it